Latest Breaking News On - Regeneron complaint - Page 1 : comparemela.com

United States - Patent - Regeneron Files Second BPCIA Complaint Against Celltrion s Proposed EYLEA® Biosimilar CT-P42

On May 17, 2024, Regeneron filed a second infringement litigation against Celltrion's proposed EYLEA® (aflibercept) biosimilar CT-P42, Case No. 1:24-cv-00053 (N.D.W. Va.).

Mylan yesafiliBiocon biologicsApril breyer menonSamsung bioepis opuvizRegeneron complaintProposed eyleaSamsung bioepisFirst two interchangeableFinal written decisions

Regeneron Files Second BPCIA Complaint Against Celltrion s Proposed EYLEA® Biosimilar CT-P42 | Venable LLP

Regeneron Files Second BPCIA Complaint Against Celltrion s Proposed EYLEA® Biosimilar CT-P42 | Venable LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

April breyer menonBiocon biologicsSamsung bioepis opuvizMylan yesafiliRegeneron complaintProposed eylea biosimilarFirst two interchangeableFinal written decisions